Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts

Pathology International

Volumn 52, Issue 9, 2002, Pages 595-606

  Oda, Yoshinao ^a   Tamiya, Sadafumi ^a   Oshiro, Yumi ^c   Hachitanda, Yoichi ^b   Kinukawa, Naoko ^a   Iwamoto, Yukihide ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

^c MATSUYAMA RED CROSS HOSPITAL   (Japan)

Author keywords

Malignant fibrous histiocytoma; Prognosis; Reassessment; Soft tissue sarcoma

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FIBROXANTHOMA; HEAD AND NECK CANCER; HISTIOCYTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LEIOMYOSARCOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MULTIVARIATE ANALYSIS; MYOFIBROBLAST; MYXOSARCOMA; PERIPHERAL NERVE TUMOR; PERITONEAL CAVITY; PRIORITY JOURNAL; PROGNOSIS; RETROPERITONEUM; RHABDOMYOSARCOMA; SARCOMA; SOFT TISSUE SARCOMA; STATISTICAL ANALYSIS; TUMOR LOCALIZATION; DERMATOFIBROMA; DIFFERENTIAL DIAGNOSIS; IMMUNOHISTOCHEMISTRY; METABOLISM; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SOFT TISSUE TUMOR; SURVIVAL RATE;

DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DIFFERENTIAL; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SOFT TISSUE NEOPLASMS; SURVIVAL RATE;

EID: 0036428682     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2002.01399.x     Document Type: Article

References (33)

1. O'Brien JE, Stout AP. Malignant fibrous xanthomas. Cancer 1964; 17: 1445-1455.
2. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma. An analysis of 200 cases. Cancer 1978; 41: 2250-2266.
3. Weiss SW, Sobin L, eds. WHO Histological Typing of Soft Tissue Tumours, 2nd Edn. Springer-Verlag, Berlin, 1994.
4. Fletcher CDM. Pleomorphic malignant fibrous histiocytoma: Fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am. J. Surg. Pathol. 1992; 16: 213-228.
5. Evans HL. Low-grade fibromyxoid sarcoma. A report of 12 cases. Am. J. Surg. Pathol. 1993; 17: 595-600.
6. Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am. J. Surg. Pathol. 1995; 19: 859-872.
7. Meis-Kindblom JM, Kindblom L-G. Acral myxoinflammatory fibroblastic sarcoma. A low-grade tumor of the hands and feet. Am. J. Surg. Pathol. 1998; 22: 911-924.
8. Enzinger FM. Angiomatoid malignant fibrous histiocytoma. A distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasm. Cancer 1979; 44: 2147-2157.
9. Costa MJ, Weiss SW. Angiomatoid malignant fibrous histiocytoma. A follow-up study of 108 cases with evaluation of possible predictors of outcome. Am. J. Surg. Pathol. 1990; 14: 1126-1132.
10. Oda Y, Miyajima K, Kawaguchi K et al. Pleomorphic leiomyosarcoma. Clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma. Am. J. Surg. Pathol. 2001; 25: 1030-1038.
11. Rubin BP, Fletcher CDM. Myxoid leiomyosarcoma of soft tissue, an unrecognized variant. Am. J. Surg. Pathol. 2000; 24: 927-936.
12. Fleming ID, Cooper JS, Henson DE et al., eds. Soft tissue sarcoma. In: American Joint Committee on Cancer Staging Manual, 5th Edn. Lippincott-Raven, Philadelphia, PA, 1998; 149-156.
13. Coindre J, Bui NB, Bonichon F, Mascarel I, Trojani M. Histopathologic grading in spindle cell soft tissue sarcomas. Cancer 1988; 61: 2305-2309.
14. Pisters PWT, Pollock RE. Staging and prognostic factors in soft tissue sarcoma. Semin. Radiation Oncol. 1999; 9: 307-314.
15. Menzel T, Calonje E, Fletcher CDM. Leiomyosarcoma with osteoclast-like giant cells. Analysis of eight cases closely mimicking the so-called giant cell variant of malignant fibrous histiocytoma. Am. J. Surg. Pathol. 1994; 18: 258-265.
16. Ramachandra S, Hollowood K, Bisceglia M, Fletcher CDM. Inflammatory pseudotumor of soft tissues: A clinicopathological and immunohistochemical analysis of 18 cases. Histopathology 1995; 27: 313-323.
17. Weiss SW, Goldblum JR. Malignant fibrohistiocytic tumors. In: Weiss SW, Goldblum JR, eds. Enzinger and Weiss' Soft Tissue Tumors, 4th Edn. Mosby, St Louis, 2001; 536-539.
18. Ozello L, Stout AP, Murray MR. Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 1963; 16: 331-344.
19. Weiss SW, Enzinger FM. Myxoid variant of malignant fibrous histiocytoma. Cancer 1977; 39: 1672-1685.
20. Fu Y-S, Gabbiani G, Kaye GI, Lattes R. Malignant soft tissue tumors of probable histiocytic origin (malignant fibrous histiocytomas): General considerations and electron microscopic and tissue culture studies. Cancer 1975; 35: 176-198.
21. Wood GS, Beckstead JH, Turner RR, Hendrickson MR, Kempson RL, Warnke RA. Malignant fibrous histiocytoma tumor cells resemble fibroblasts. Am. J. Surg. Pathol. 1986; 10: 323-325.
22. Brooks JJ. The significance of double phenotypic patterns and markers in human sarcomas. A new model of mesenchymal differentiation. Am. J. Pathol. 1986; 125: 113-123.
23. Mentzel T, Calonje E, Wadden C et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on low-grade variant. Am. J. Surg. Pathol. 1996; 20: 391-405.
24. Schürch W, Begin LR, Seemayer TA et al. Pleomorphic soft tissue myogenic sarcomas of adulthood. A reappraisal in the mid-1990s. Am. J. Surg. Pathol. 1996; 20: 131-147.
25. Yamamoto I, Oshiro Y, Fukuda T, Tsuneyoshi M. Pleomorphic leiomyosarcoma of soft parts: A reassessment by histology and immunohistochemistry of pleomorphic soft tissue sarcomas. Oncol. Reports 1999; 6: 533-537.
26. Hollwood K, Fletcher CDM. Malignant fibrous histiocytoma: Morphologic pattern or pathologic entity? Semin. Diag. Pathol. 1995; 12: 210-220.
27. Fletcher CDM. Soft tissue tumors. In: Fletcher CDM, ed. Diagnostic Histopathology of Tumors, 2nd Edn. Churchill Livingstone, London, 2000: 1511-1513.
28. Fletcher CDM, Gustafson P, Rydholm A, Willen H, Akerman M. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: Prognostic relevance of subclassification. J. Clin. Oncol. 2001; 19: 3045-3050.
29. King ME, Dickerson GR, Scully RE. Myxoid leiomyosarcoma of the uterus. A report of six cases. Am. J. Surg. Pathol. 1982; 6: 589-598.
30. Hashimoto H, Daimaru Y, Takeshita S, Tsuneyoshi M, Enjoji M. Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer 1992; 70: 2816-2822.
31. Coindre JM, Terrier P, Bui NB et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J. Clin. Oncol. 1996; 14: 869-877.
32. Salo JC, Lewis JJ, Woodruff JM, Leung DH, Brennan MF. Malignant fibrous histiocytoma of the extremity. Cancer 1999; 85: 1765-1772.
33. Le Doussal V, Coindre JM, Leroux A et al. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: A multicenter study of 216 patients with multivariate analysis. Cancer 1996; 77: 1823-1830.